eCancer

A new study led by UC San Francisco has found an alarming rise in invasive breast cancer among Asian American women over the last two decades. Rates are rising among nearly all Asian American ethnic groups much faster than they are in any other U.S. ethnic group; and this is especially true among women who are under 50 and have advanced stage or certain aggressive subtypes of breast cancer.

A new study from University Hospitals Connor Whole Health reports that an insurance-supported integrative oncology programme resulted in clinically meaningful improvements in cancer-related symptoms like pain, stress, anxiety, depression, nausea, and fatigue. The findings highlight a scalable model with potential for delivering future integrative therapies within routine oncology care. The findings from this study were recently published in JCO Oncology Practice.

A healthy bone marrow (BM) produces nearly all types of cells in our blood. Many blood disorders occur when hematopoietic stem cells (HSCs) in the BM malfunction. Many blood disorders and cancers are treated with radiation or chemotherapy, which as a side effect depletes not only tumour cells but also hematopoietic cells including HSCs in the BM—a condition known as myelosuppression. In severe cases, HSC transplantation (HSCT) is required to restore hematopoiesis.

In a global breakthrough published in Nature Genetics, researchers have successfully mapped the cells and genes that regulate bone formation and loss at an unprecedented scale and discovered the critical role that blood vessel cells play in bone health.

A new study led by researchers at the Icahn School of Medicine at Mount Sinai found that although the overall number of radiation oncology clinics in the United States has appeared stable in recent years, many individual treatment centres have quietly closed while others have opened. The closures have disproportionately affected rural and freestanding practices, reducing access to lifesaving radiation therapy for patients to receive lifesaving cancer treatment close to home.

A form of glioma, a type of brain cancer, tends to progress towards greater malignancy due to an increasing tendency of the glioma cells to transform into immature, stem-cell-like states, according to a study led by investigators at Weill Cornell Medicine, the New York Genome Centre, Harvard Medical School and Mass General Brigham.

ecancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next. Kuala Lumpur Convention Centre (KLCC), Kuala Lumpur, Malaysia GIN2026 is the leading global gathering dedicated to evidence-based healthcare, guideline development and implementation.

On July 10, 2026, the Food and Drug Administration approved pembrolizumab or pembrolizumab and berahyaluronidase alfa-pmph each in combination with enfortumab vedotin-ejfv as neoadjuvant treatment (before surgery) followed by adjuvant treatment after cystectomy (surgery to remove the bladder) for adults with muscle invasive bladder cancer (MIBC).

Although opioids remain indispensable for pain relief in patients with advanced cancer, their use frequently results in OIC, which can substantially reduce the quality of life and, in some cases, compromise the continuation of optimal pain management. Naldemedine, a peripherally acting μ-opioid receptor antagonist, is used to treat OIC by preserving physiological bowel motility without interfering with central analgesia.

On July 9, 2026, the Food and Drug Administration approved isatuximab-irfc for subcutaneous injection for multiple myeloma indications.